Insider Transactions in Q2 2025 at Bio Xcel Therapeutics, Inc. (BTAI)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2025
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35
+2.07%
|
-
|
|
Jun 15
2025
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
219
+4.65%
|
-
|
|
Jun 15
2025
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35
+1.77%
|
-
|
|
Jun 15
2025
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35
+2.37%
|
-
|
|
Jun 14
2025
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33
+1.99%
|
-
|
|
Jun 14
2025
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
163
+3.68%
|
-
|
|
Jun 14
2025
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33
+1.7%
|
-
|
|
Jun 14
2025
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33
+2.29%
|
-
|
|
May 31
2025
|
David J. Mack Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,693
+12.5%
|
-
|
|
Apr 30
2025
|
David J. Mack Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,693
+14.29%
|
-
|